Precision-Engineered Triterpenoid: The Cornerstone of Deep Dermal Rejuvenation & Structural Reconstruction
The Botanical Bottleneck
Natural pentacyclic triterpenes like Ursolic Acid possess exceptional biological activities, but face severe cosmetic limitations:
Extremely poor lipophilicity restricts formulation versatility.
Low skin penetration limits clinical bioavailability.
High propensity to crystallize destabilizes emulsions.
The Solution: By introducing a benzyl group, we fundamentally shift the molecule’s partition coefficient, creating a highly bioavailable, oil-soluble powerhouse.
Mechanism of Action
Bioavailability Shift
The structural transformation from Ursolic Acid to Ursolene™ BZ is rooted in a fundamental alteration of the lipid-water partition coefficient.
This precise structural modification transforms a traditional botanical extract into a pharmaceutical-grade, oil-soluble active that seamlessly crosses the stratum corneum to reach deep dermal targets.
In Vitro Efficacy
Dermal Architecture Support
Our rigorous efficacy testing matrix demonstrates statistically significant improvements compared to vehicle and unmodified free ursolic acid controls.
Tested on primary human fibroblasts at 10 μM concentration (p < 0.01). The dramatic reduction in UV-induced elastase activity ensures the preservation of the skin’s vital recoil capacity.
In Vivo Clinical Results
A double-blind, placebo-controlled clinical study on 30 female volunteers (aged 45-65), applying a 0.2% PuriActives® Ursolene™ BZ cream twice daily for 28 days.
Stability Comparison
Comparative analysis of formulation stability and lipid solubility scores (measured as a relative percentage of an ideal oil-soluble active profile).
Technical Guidelines
Sustainable Sourcing
Target Applications
The perfect synergy of a naturally derived core and rational structural design, bridging the gap between pharmaceutical-grade precision and cosmetic applicability.
